1

INSTRUCTIONS TO AUTHORS

Clinical report or Case report

Clinical or Case report article (Fewer than 1500 words including summary (no longer than 150 words) text references legend to figures and tables)

A clinical report describes observations of one or several rare cases whose originality must be demonstrated by a detailed study of the literature. They include the description of the observation(s) reported, followed by a discussion or comments showing the significance of the case(s) and if relevant comparing the new observations with cases that have already been published. The clinical report should modify the current clinical practice by reporting diagnostic dilemma or unusual treatment or complications. Entities that occur coincidentally are not relevant for clinical reports.

Must follow the GUIDELINES in (see guidelines Authors OTSR)

Your manuscript should be introduced in the following template: (see below).

General Guidelines for Clinical Follow-up:

A minimum of 5 years of follow-up is mandatory for papers related to total joint arthroplasty with the exception of unexpected complications or failures rates (without minimal follow-up).

A minimum of 2 years of follow-up is mandatory for papers related to infection (except in case of failure or unusual results). Criteria for infection healing and diagnosis must be clearly defined.

A minimum of 1 year of follow-up is mandatory for papers reporting trauma and 2 years for papers reporting management of ligament injuries (except in case unexpected rate of failure).

A minimum times corresponding to median time for recurrence is recommended for papers reporting tumors.

For papers reporting mechanical or biological models (in vitro testing, finite element analysis, mechanical testing) there is no minimal time of follow-up required but reproducibility of the model or criteria of assessment is strongly advised.

Authorship and conflict of interest

We recommend the number or authors to be limited to 6, particularly for case reports. It is important that all authors have a real participation in any part of the study (surgery, laboratory of mechanical experiments, data collection, manuscript edition, statistics). It is corresponding author responsibility to check if all authors have this adequate participation. Whatever the number, all authors must submit a separate filled ICMJE file (to assess conflict of interest see below) that should be enclosed in the electronic submission. Conflict of interest should be declared regarding the submitted paper as well as any conflict outside the paper that may have any relation to the work. Conflict of interest should be detailed for each author at the end of the manuscript.

12

1

2

3

45

6789

101112

13

14

15

16

171819

202122

232425

2627

28293031

32

333435363738394041

2

The journal follows the international practices relative to potential conflicts of interest in the submitted articles. Any manuscript submission must include a conflict of interest disclosure statement. A conflict of interest exists when an author and/or co-author has financial or personal relationships with other persons or organizations that may influence professional judgment concerning an essential value (patient’s well-being, research integrity, etc.). The main conflicts of interest are financial interests, clinical trials, occasional consultancies, family relations, etc. All authors of the publication must disclose any financial or personal relationships that could be considered as having a potential conflict of interest only bearing on the subject matter of the text published.1. If there is no conflict of interest in relation with the article submitted, the following statement must be added directly in the manuscript: Conflict of interest: none2. If there is one (or several) conflict(s) of interest with one or several authors of the article, the complete list of these conflicts of interest must be mentioned at the end of the manuscript, before the bibliographical references and following the presentation below, with the initials of the authors concerned and the name of the company, as in the examples below.Examples of conflict of interest statements, TO BE ADDED AT THE END OF THE TEXT, under the acknowledgments (if present):- C. R., E. L. Financial interest in Barbot S.A.;- E. L. Owner, director, employee, participation in a company’s decision body;- Other regular activities in Chups SAS;- J.-J. E. Clinical trials: as principal investigator, coordinator or main researcher for RTM SARL;- P. L. Clinical trials: as co-investigator, associate researcher collaborator in the study for Light & Co;- F. W. Occasional consultancies: expert reports for EFS Associated;- M. D. Occasional consultancies: consultancies for SFC;- C. G. Conferences: invitations as a presenter for KKS & Son;- M. S. Conferences: invitations as an auditor (travel expenses paid by a company) for Régis SA;- C.-A. S. Substantial contributions to the budget of an institution under author’s responsibility, Aphelion;- M. F. Close relatives employed in the companies declared below;- A.D. Conflict of interest: none.3. If no conflict of interest disclosure statement has been included by the author (co-authors), the following statement will be published in the article: Conflict of interest: the authors have not included a conflict of interest disclosure statement.

See editorial Beaufils P. Disclosure of interest or conflict of interest? Orthop Traumatol Surg Res 2012;98(4):367-8. (See OTSR June 2012 Editorial Beaufils)

OTSR agrees to use the “Uniform Requirements for manuscripts submitted to biomedical journals” (http://www.icmje.org/). Each author should include in the electronic submission an ICMJE file filed (http://www.icmje.org/coi_disclosure.pdf.).

34

4243444546474849505152535455565758596061626364656667686970717273747576777879

808182

838485

3

Ethical Review Committee Statement

When required (new devices, new treatments) an ethical board review committee statement should be submitted enclosed in the electronic submission.

General additional informationAll medications and other drugs should appear under their international nonproprietary name, with the trade name followed by ® in a footnote including the manufacturing laboratory and its head-office. Surgical materials and implants should be written under their generic name with a footnote mentioning the manufacturer’s name, its head office, and the trade name of the device followed by ™. The units of measure for length, height, weight, and volume must be in the metric system or their multiples. Temperatures must be in degrees Celsius and blood pressure in millimeters of mercury. The hematological and biochemical measurements should be expressed according to the International System of Units. Any abbreviation or acronym is written out in full followed by the abbreviation in parentheses at its first mention in the text. Anatomical descriptions should use the international nomenclature (anatomica parisiensis).

PLEASE REMOVE ALL INSTRUCTIONS PRIOR TO UPLOADING FINAL DRAFT TO EDITORIAL MANAGER

56

8687

888990919293949596979899

100101102103104105106

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 4

Title page and followings

This page must include the following:

Title (containing fewer than 280 characters including spaces)

Running title (containing fewer than 80 characters including spaces)

Author name(s) (and Christian name ) (must follow authorship guidelines at (see guidelines Authors OTSR) and the affiliation

The affiliation(s), and full postal address (including ZIP code and country). Please use the vermicular language according to the country of the authors.

Identification of the corresponding author with e-mail address.

Authors must declare is they had or if their institution had industrial or institutional or academic grants or financial support regarding the current study.

The followings pages must include

Ethical review committee statement if mandatory.

Word Count (from title to the end of manuscript including tables, legend to figures and references): Maximum is 1500 words for case report.

789

107

108

109

110

111112

113114

115

116117

118

119

120

121122

123

124

125

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 5

Abstract Your Abstract must contain fewer than 150 words.

The following features should be included in the abstract: What is the current clinical

practice or usual evolution of the considered disease. What arguments may justify the

publication of this clinical report? Briefly describe the case report regarding

underlining the main results. What is the relevant conclusion, according to the

literature analysis, to modify the management of the considered disease or the surgery

or clinical or biological test?

Level of Evidence: Below Abstract provide a level of Evidence (usually case reports are

rated as level IV historical case) (see guidelines Authors OTSR).

Key Words: Three to five key words in English should immediately follow the abstract,

chosen among the English key words of the Index Medicus Medical Subject Headings.

101112

126

127

128

129

130

131

132

133

134

135

136

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 6

1. Introduction (maximum of 200 words)

What is the current clinical practice or usual evolution of the considered disease? What

arguments may justify the publication of this clinical report? Does this complication or

unusual evolution of the disease was previously published (a minimal literature analysis

is mandatory)

2. Case description (maximum of 300 words)

Briefly describe the case report. Describe the history, physical examination, laboratory

tests and imaging, treatment, and follow-up of each case. If more than one case are

reported please summarize in a table to prevent excessive length of the manuscript.

Please focus on major data related to the clinical situation (minimal demographics,

minimal function assessment, etc.)

3. Discussion (maximum of 500 words)

Please perform a brief literature review that justify your case report is original and may

modify the current clinical practice. Use of table(s) could be recommended to prevent

excessive length of discussion section. End the discussion by the clinical relevance (i.e.

what is really new, the message to take home)

131415

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 7

Acknowledgments

Note any acknowledgments. Begin with, “We thank…” and note the nature of the

contribution.

Conflict of interest

Conflict of interest disclosure statement. See above and at (see guidelines Authors

OTSR)

161718

153

154

155

156

157

158

159

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 8

References

All references cited in the text must be included in the reference list. All the

references in the reference list must be cited in the text by a number between square

brackets. If the reference includes more than 6 authors, the six first are cited followed

by “et al.”

All the references used should be accessible to the reader, which excludes personal

communications, unpublished data, doctoral dissertations, and conference papers that

have not been published.

The reference list should be presented separately at the end of the article.

The reference list should be supplied at the end of the manuscript; the references

should be listed and numbered in the order they appear in the text using Arabic

numerals.

References to Revue de Chirurgie Orthopédique should cite: - before 1 January 2009:

the French-language journal (Rev Chir Orthop) with the title in English. - after 1

January 2009: only the English-language journal (Orthop Traumatol Surg Res)

Journal titles are abbreviated following the U.S. National Library of Medicine

nomenclature. Examples of references:

Journal article:1. Lecerf G, Fessy MH, Philippot R, Massin P, Giraud F, Flecher X, et al. Femoral

offset: anatomical concept, definition, assessment, implications for preoperative

templating and hip arthroplasty. Orthop Traumatol Surg Res 2009;95:210-9.

192021

160161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178179

180

181

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 9

2. Viste A, Chouteau J, Testa R, Chèze L, Fessy MH, Moyen B. Is transverse

acetabular ligament an anatomical landmark to reliably orient the cup in primary

total hip arthroplasty? Orthop Traumatol Surg Res 2011;97:241-5.

Journal supplement:

1. Gleyze P, Clavert P, Flurin PH, Laprelle E, Katz D, Toussaint B, et al.

Management of the stiff shoulder. A prospective multicenter comparative study of the

six main techniques in use: 235 cases. Orthop Traumatol Surg Res 2011;97(8

Suppl):S167-81.

Book:

1. Neyret P, Demey G. Traité de chirurgie du genou. 1st ed. Paris: Elsevier Masson;

2012.

Book chapter:

1. Glick JM. Complications of hip arthroscopy by the lateral approach. In: Shermann

OH, Minkoff J, editors. Current management of orthopaedics: arthroscopic surgery.

Baltimore: W. Wilkins; 1990. p. 1-9.

Publication of conference papers:

1. Trojani C. Traumatic acromio- and sternoclavicularcjoint dislocation. In: Huten D,

editor. Cahiers d’enseignement de la SoFCOT: conférences d’enseignement. Paris:

Elsevier Masson; 2011 [p.21-48].

Articles in press are cited as above, followed by: in press, year of publication.

222324

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 10

In-text citations should appear before commas and periods and located in a sentence

immediately after the point they are documenting.

252627

202

203

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 11

Tables

Tables with table legends and table footnotes at the bottom of the table. Each table should appear on

a separate sheet. Tables should be numbered in order of citation in the text. They should be

numbered in Arabic numerals in the order they are first cited in the text. (1, 2, 3,...). Any results that

can be expressed typographically can be presented in tables, provided that they are clearly

presented. For small clinical series, a summary table can display all the data for each of the

observations. Each table must be cited in the text. Each table should be headed by an informative

title and any explanations or notes concerning the units of measure, abbreviations, or statistics

should be footnoted below the table. The tables should not be included in the body of the

manuscript.

11

282930

204

205

206

207

208

209

210

211

212

213

214

31

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 12

Legends to figures

Figure legends should be on separate pages from the manuscript.

The figures are cited in the text by number (Arabic numerals) in the order they appear in the

text. They must be separate from the text, i.e., not integrated into the text file. The figures

(diagrams, drawings, color or black-and-white photos, videos [for the electronic version],

histograms, graphs) should always be provided in separate files, one file for each figure, or in a

zipped file with one file per figure. The figures can be supplied in color: they will be published

in color in the electronic versions (OTSR and RCOT) and in black and white in the paper

version (RCOT).

All problems should be addressed to: authorsupport@elsevier.com

The figure legends are placed after the text (see above). The figures reinforce the text to

illustrate or present the results that cannot be presented as a table. Figures comprise

photographs, radiographs but also histograms and graphs. Figures should be provided in TIFF

(.tif), EPS (.eps), or PDF (.pdf) format. Accepted formats for videos are MPG-1 and MPG-2

(.mpg), MPEG-4 (.mp4), AVI (.avi), GIF (.gif), and Quicktime movie (.mov). Word,

Powerpoint, and Excel formats should be avoided. To allow the editor to easily identify the

figures, please name the files with the figure number and the format used, e.g., “fig1.tif.”

The minimum resolution for the figures should be 300 dpi for black-and-white or color

photographs and 500-1000 dpi for graphs or diagrams. High resolution is absolutely necessary

for printing.

For any use of a figure and text already published, the author must provide the written

permissions letter. The author must make the request from the publisher and/or author of the

original publication.

12

323334

215216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

35

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 13

Illustrations with multiple figures (eg, 1A, 1B, 1C) must be labeled "A," "B," and "C" in the

lower left hand corner. Each illustration requires a separate legend.

Figures should be uploaded and separately labeled in EES.

13

363738

240

241

242

39

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 14

STROBE Guidelines for authors of OTSR

To be used by authors of all observational clinical studies published in OTSR. For this purpose a cohort study (the term used by STROBE) is considered a longitudinal study typically reporting outcomes of treatment in one or more cohorts; a case-control study is one identifying factors in outcomes; a cross-sectional study is one to identify the prevalence of factors or characteristics in a population at a single point in time. This checklist table is modified from The STROBE Initiative, www.strobe-statement.org and should be filled and submitted within the electronic submission

Item No

Recommendation

Please insert check where included or N/A where not applicable

Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was found

IntroductionBackground/rationale 2 Explain the scientific background and rationale

for the investigation being reportedObjectives 3 State specific objectives, including any pre

specified hypotheses

MethodsStudy design 4 Present key elements of study design early in the

paperSetting 5 Describe the setting, locations, and relevant

dates, including periods of recruitment, treatment, follow-up, and data collection

Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-upCase-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controlsCross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants(b) Cohort study—For matched studies, give matching criteria and number of treated and untreatedCase-control study—For matched studies, give matching criteria and the number of controls per case

Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable

Data sources/ measurement

8* For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group

14

404142

243244245246247248249250251252

43

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 15

Bias 9 Describe any efforts to address potential sources of bias

Study size 10 Explain how the study size was arrived atQuantitative variables 11 Explain how quantitative variables were handled in

the analyses. If applicable, describe which groupings were chosen and why

Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) If applicable, explain how loss to follow-up was addressed(e) Describe any sensitivity analyses

ResultsParticipants 13* (a) Report numbers of individuals at each stage

of study—eg, numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed(b) Give reasons for nonparticipation at each stage

Descriptive data 14* (a) Give characteristics of study participants (eg, demographic, clinical, social) and information on other treatments and potential confounders(b) Indicate number of participants with missing data for each variable of interest(c) Cohort study—Summarize follow-up time (eg, average and total amount)

Outcome data 15* Report numbers of outcome events or summary measures over time

Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses

DiscussionKey results 18 Summarise key results with reference to study

objectivesLimitations 19 Discuss limitations of the study, taking into account

sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias

Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence

Generalisability 21 Discuss the generalisability (external validity) of the study results

Other informationFunding 22 Give the source of funding and the role of the funders

15

444546

47

Template for Clinical Report – Orthopaedics & Traumatology: Surgery & Research 16

for the present study and, if applicable, for the original study on which the present article is based

*Give information separately for cases and controls.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. Information on the STROBE Initiative is available at http://www.strobe-statement.org.

16

484950

253254255256257258259260261

51